- Home
- BDX
as 06-20-2025 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 49.0B | IPO Year: | 1962 |
| Target Price: | $231.50 | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.16 | EPS Growth: | 14.07 |
| 52 Week Low/High: | $163.33 - $251.99 | Next Earning Date: | 08-07-2025 |
| Revenue: | $20,867,000,000 | Revenue Growth: | 5.84% |
| Revenue Growth (this year): | 9.3% | Revenue Growth (next year): | 4.88% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Shan David | BDX | EVP and Chief ISC Officer | Jun 2 '25 | Sell | $171.19 | 1,166 | $199,607.54 | 4,575 | |
| Garrison Michael David | BDX | EVP & President, Medical | Apr 9 '25 | Sell | $197.28 | 479 | $94,497.12 | 4,887 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
Yahoo Finance Video
12 days ago
As tech leads, which stocks have outperformed since April 8 rout?
Benzinga
13 days ago
Here's How You Can Earn $100 In Passive Income By Investing In Becton Dickinson Stock
Zacks
17 days ago
Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue?
StockStory
17 days ago
3 Healthcare Stocks Skating on Thin Ice
MT Newswires
18 days ago
Barclays Adjusts Price Target on Becton, Dickinson and Company to $241 From $261
MT Newswires
19 days ago
Goldman Sachs Adjusts PT on Becton Dickinson and Co. to $196 From $192, Maintains Neutral Rating
Yahoo Finance
20 days ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
Moneywise
20 days ago
‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.